REDITREX
Cumberland Pharmaceuticals Inc.
Application Filed: 2017-11-28
Trademark Application Details
SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87700133 |
| Registration Number | 6034222 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Kristina Montanaro Schrader |
| Attorney Docket Number | 604816-14 |
| Law Office Assigned | N50 |
| Employee Name | ALLEN, BIANCA LEIGH |
Timeline
| 2017-11-28 | Application Filed |
| 2018-09-04 | Published for Opposition |
| 2019-10-09 | Date of First Use |
| 2019-12-20 | Location: TMEG LAW OFFICE 105 |
| 2019-12-20 | Status: Live/Pending |
| 2019-12-20 | Transaction Date |
| 2020-04-14 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Cumberland Pharmaceuticals Inc. |
| Address | Suite 950 2525 West End Avenue Nashville TN 37203 |
| Legal Entity Type | Corporation |
| Legal Entity State | TN |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Anti-arthritic compositions and preparations; analgesic compositions and preparations; chemical preparations for pharmaceutical or medical purposes for treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the prevention and treatment of auto immune diseases and disorders; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical products for the treatment of joint disease |
| GS0051 | Anti-arthritic compositions and preparations; analgesic compositions and preparations; chemical preparations for pharmaceutical or medical purposes for treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the prevention and treatment of auto immune diseases and disorders; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical products for the treatment of joint disease |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-12-01 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-12-08 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-01-22 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-01-29 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2018-01-29 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-01-29 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-07-16 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-07-16 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-07-16 | 9 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-07-23 | 10 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-08-15 | 11 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-09-04 | 12 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-09-04 | 13 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-10-30 | 14 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-04-15 | 15 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2019-04-15 | 16 EXT1 S: |
| EXTENSION 1 GRANTED | 2019-04-15 | 17 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-04-17 | 18 EXRA E:E-Mail |
| TEAS STATEMENT OF USE RECEIVED | 2019-10-29 | 19 EISU I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2019-11-09 | 20 AITU A:Allowance for Publication |
| USE AMENDMENT FILED | 2019-10-29 | 21 IUAF S: |
| STATEMENT OF USE PROCESSING COMPLETE | 2019-11-09 | 22 SUPC I:Incoming Correspondence |
| SU - NON-FINAL ACTION - WRITTEN | 2019-11-26 | 23 CNRT W: |
| NON-FINAL ACTION E-MAILED | 2019-11-26 | 24 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-11-26 | 25 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-12-05 | 26 TROA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2019-12-17 | 27 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-12-20 | 28 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-12-20 | 29 TEME I:Incoming Correspondence |
| SU - FINAL REFUSAL - WRITTEN | 2020-01-07 | 30 CNFR W: |
| FINAL REFUSAL E-MAILED | 2020-01-07 | 31 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2020-01-07 | 32 GNFN O:Outgoing Correspondence |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2020-02-11 | 33 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-02-12 | 34 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-02-12 | 35 TEME I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2020-02-26 | 36 DOCK D:Assigned to Examiner |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2020-03-09 | 37 CNPR P: |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2020-03-10 | 38 SUNA E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2020-04-14 | 39 R.PR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-04-22 | 40 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-04-22 | 41 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-04-22 | 42 TCCA I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-01-16 | 43 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-01-16 | 44 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-01-16 | 45 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-01-16 | 46 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-01-16 | 47 CHAN I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2023-08-23 | 48 ASGN I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-08-29 | 49 COAR I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-08-29 | 50 CHAN I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-08-29 | 51 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-08-29 | 52 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2023-08-29 | 53 ECDR I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-08-29 | 54 TCCA I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 